Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category

Executive Summary

• Doseology Sciences Inc. began trading on the OTCQB Venture Market under the ticker DOSEF, expanding U.S. investor access.
• The company appointed Larry Latowsky as Executive Chairman of the Board to support compliance with the new listing requirements.
• An aggregate of 75,000 pre‑funded warrants (priced at $1.00 each) were issued to the vendor of the “Feed That Brain” acquisition; a further 75,000 warrants will be issuable on the one‑year and eighteen‑month anniversaries of that closing, subject to a four‑month hold period expiring July 11 2026.

Key Details

• OTCQB Listing: Common shares now trade on the OTCQB Venture Market (United States) under symbol DOSEF.
• Executive Appointment: Larry Latowsky named Executive Chairman of the Board of Directors.
• Pre‑Funded Warrants – Initial Issuance: 75,000 warrants issued to the acquisition vendor at a deemed price of $1.00 per warrant, representing total consideration of $75,000.
• Future Warrant Issuances: Additional 75,000 pre‑funded warrants may be issued on the one‑year and eighteen‑month anniversaries of the acquisition closing, per the asset purchase agreement.
• Hold Period: The warrants are subject to a four‑month hold period; this period will expire on July 11 2026.
• Strategic Context: Listing aligns Doseology with higher transparency and reporting standards, supporting its growth strategy in the emerging oral stimulant pouch market.

Notable Quotes

“We are pleased to expand trading access for U.S. investors through the OTCQB market,” said Chris Jackson, CEO of Doseology Sciences Inc.

All non‑material boilerplate, forward‑looking statements, and disclaimer text have been omitted.